Theranexus Société Anonyme announced that it has issues 1,930,009 common shares at a price of â¬1.28 million for the gross proceeds of â¬2.470412 million on July 12, 2023. The transactions included participation from Beyond Batten Disease Foundation and individual investors.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 EUR | -3.03% | -0.88% | 0.00% |
Apr. 19 | Theranexus: share price rises following promising trial results | CF |
Mar. 11 | Theranexus: CEO takes over as Chairman of the Board | CF |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.6M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.18% | 22.18B | |
-16.67% | 21.2B | |
-9.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ALTHX Stock
- News Theranexus
- Theranexus Société Anonyme announced that it has received €2.470412 million in funding